Autism is a neuro developmental disorder that affects social interaction, communication, interests and behavior. Stem cell therapy has played a major role to treat autistic children. People use stem cells from umbilical cord blood as a treatment for autism. Unistem provides Stem Cell Treatment for Autism in India. Know more about autism stem cell therapy india.
Hearing Loss occurs due to many different causes and it can be treated successfully with medication and advance surgery as well. Unistem Biosciences provides the best Hearing Loss Treatment in India through stem cell therapy.
Hearing loss is one of the most widespread sensory disorders. We use Stem Cells from Umbilical Cord Blood for Hearing Impairment. Know more about Stem Cell Treatment for Hearing Loss India.
Ligaments connect bones to other bones in and around joints. Due to Injury They can be very much painful and debilitating. They can even permanently change your lifestyle. knee ligament injuries also happen while playing sport or running.
Through stem cell treatment using the patient’s own stem cells, the original and best ACL can be regenerated. Stem cell therapy injection play a major role opposite of surgery, it rebuilds and strengthens damaged tissue as opposed to removing it. Know More About Stem Cell Treatment Knee Pain.
Umbilical Cord blood is blood that remains in the placenta and umbilical cord when a baby is born. It is very rich resource of stem cells, Umbilical cord stem cells are used to cure illnesses and disorders.
Cord blood collected from umbilical cord with the patent’s consent of new born child. It is becoming the future of medicine for threatening diseases like neurodegenerative diseases and conditions, diabetes, heart disease.
Learn all about newborn baby stem cells, including what makes umbilical cord blood stem cells so special. Read more about umbilical cord blood stem cell treatment.
Glaucoma causes damage to the optic nerve and affect your vision as well as cause pain. Optic nerve contains more than a million nerve fibrers that connect the retina. There are number of diseases that damage the optic nerve and can lead to vision loss. Know more about optic nerve stem cell treatment
Osteoarthritis is a common rheumatologic disorder. OA is a joint disease that mostly affects cartilage. Pain and stiffness occurs most often in knees and hands. Osteoarthritis is also know as degenerative joint disease.
nice post about stem cell therapy.
As mentioned in Stem Cells: the fundamentals earlier in this magazine, stem cell cloning generally refers to the creation of an embryonic stem cell from a somatic cell nucleus and an egg cell. This is done by somatic cell nuclear transfer (SCNT). The reason why Hwang and colleagues gained so much temporary fame for the 2005 and 2006 stem cell cloning articles (the story of Hwang and his fraudulent papers are described earlier in this magazine), is the great potential that lies in mastering this technology. However, this has been practiced for over a decade already, namely in the cloning of animals.
Since the birth of Dolly the sheep in 1996, the first cloned mammal, the list of species which have been cloned has grown long; cats, dogs, mice, fish, horses, pigs and rats to mention a few (1, 2). The birth of a cloned animal always gets news coverage…
View original post 741 more words
A category of adult stem cells is represented by mesenchymal stem cells. Mesenchymal stem cells are found in very large numbers in the bone marrow and Wharton’s Jelly region of the umbilical cord (Wharton’s Jelly or “Wharton jelly” is mucoid connective tissue that constitutes the extracellular matrix of the umbilical cord and includes blood vessels, protecting them).
Mesenchymal stem cells are the source of development of various tissue structures (e.g. nerve tissue, heart tissue, muscle tissue, bone tissue and so on). As hematopoietic stem cells, mesenchymal stem cells are defined by three fundamental characteristics: low specialization, increased auto replication capacity (multiplication), the ability to differentiate, giving rise to mature cells capable to perform functions in the body.
Mesenchymal stem cells in umbilical cord : antigenicity (the ability to trigger an immune response)-being very well tolerated in the immunological point of view in the context of a transplant are easily taken the mesenchymal stem cells, can be isolated in a section of umbilical cord blood collected at birth. They may be available as soon as requested by authorized clinics in therapies with such cells, they have high compatibility, they show the ability of high multiplication-being known as that of multiplication and differentiation capacity cell decreases with increasing age, the dealer’s.
The number of mesenchymal stem cells in bone marrow decreases from a stem mesenchymal cell – 10,000 mononucleate cells from newborns to 1/100,000 in teens, reaching finally to 1/1,000,000 in adults.
In addition, the number of adult mesenchymal stem cells is 1000-5000 cells stem/cm3 of blood cord and 10,000-15,000/cm of cord tissue.
Due to their high plasticity, mesenchymal stem cells can differentiate into bone cells, cartilage, nerve, kidney; liver is a real perspective of regenerative medicine, with the potential for tissue and organs regeneration.
Clinical trials have demonstrated that by their actions and immunosuppressive action, mesenchymal stem cells transplantation with hematopoietic stem cells reduce the rejection probability due to imperfect compatibility of hematopoietic stem cells in alogenic transplant.
Mesenchymal stem cells are going to be extremely useful in the treatment of autoimmune and inflammatory diseases, such as rheumatoid arthritis and Chron’s disease due to their immunomodulatory potential.
Recent research in the field of tissue engineering has demonstrated the possibility of obtaining of valves and capillaries.
Also still in clinical trials, mesenchymal stem cells are used as transport vehicles for antitumor drugs, gene therapy in treatment of hard-to-reach goal.
Ataxia is feeling of imbalance, lack of coordination lack of control during movement, it is a manifestation of many neurological disease which are hereditary as well as non-hereditary like conditions such as SCA1, SCA2, SCA3 (Machado-Joseph Ataxia), SCA6, Friedreich Ataxia and Ataxia caused by brain injury, sensory ataxia etc
Stem cells have been used to treat patients diagnosed with Ataxia since 2007. Over the last few years different types of Ataxia were treated, such as SCA1, SCA2, SCA3 (Machado-Joseph Ataxia), SCA6, Friedreich Ataxia and Ataxia caused by brain injury. Patients with Ataxia see their condition getting progressively worse because of the constant loss of nerve cells in their brain/spinal cord. Thus, the aim of therapy for Ataxia is to regenerate patient’s lost nerve cells and restore there lost function by using stem cell transplantation. To do so, stem cells are injected in great quantity through IVs and lumbar punctures in order to better target the damaged areas.
Many clinical trials have been conducted worldwide to see if Mesenchymal stem cells have potential to improve symptoms of ataxias; the results so far are encouraging with level 4 evidence of safety and efficacy in certain conditions.
Before trying stem cell therapy patients should undergo other standard treatments (if available), they should ask what kind of stem cell is being used and if that particular stem cell is suitable for their disease.
Graft versus host disease (GVHD) is a difficult and potentially lethal complication of Bone Marrow stem cell transplantation and few other organ transplantations. It occurs with minor human leucocyte antigen (HLA) mismatch and is normally treated with corticosteroid and other immunosuppressive treatments/drugs. When it is not responding to steroid therapy, then mortality reaches up to 80%. Mesenchymal stem cells (MSCs) are versatile cells found in umbilical cord and other tissues.
They can be expanded i.e cultured and have potent and diverse immunomodulatory property. Additionally, human mesenchymal stem cells carry low levels of class 1 and no class 2 HLA antigens, thereby making them immunoprivileged and hence can be used without HLA matching under certain circumstances. Their use in steroid-refractory graft versus host disease was first described in 2004. Subsequently, they have been used in a number of Phase I and II trials in acute and chronic graft versus host disease trials with success.
Canadian and New Zealand FDAs have recently given approvals for the use of bone marrow MSCs in humans